keyword
https://read.qxmd.com/read/38586468/association-between-tobacco-product-use-and-respiratory-health-and-asthma-related-interference-with-activities-among-u-s-adolescents
#1
JOURNAL ARTICLE
Tingting Yao, Shannon Lea Watkins, Hai-Yen Sung, Yingning Wang, Dian Gu, Joanne Chen Lyu, James Lightwood, Wendy Max
Tobacco use adversely affects long-term respiratory health. We examined the relationship between sole and dual tobacco product use and both respiratory health and respiratory-related quality of life during adolescence in the U.S. Using adolescent data (baseline age 12-17) from Waves 4.5 (data collected from December 2017-December 2018) and 5 (data collected from December 2018-November 2019) of the Population Assessment of Tobacco and Health Study, we examined the associations between combustible (i.e., cigarette or cigar), vaped, and dual (i...
May 2024: Preventive Medicine Reports
https://read.qxmd.com/read/38343856/longitudinal-associations-between-exclusive-dual-and-polytobacco-use-and-respiratory-illness-among-youth
#2
Luis Zavala-Arciniega, Steven Cook, Jana Hirschtick, Yanmei Xie, Richa Mukerjee, Douglas Arenberg, Geoffrey D Barnes, David T Levy, Rafael Meza, Nancy Fleischer
Background The health consequences of polytobacco use are still well not understand. We evaluated prospective associations between exclusive, dual, and polytobacco use and diagnosed bronchitis, pneumonia, or chronic cough among US youth. Methods Data came from Waves 1-5 of the Population Assessment of Tobacco and Health Study. We categorized time-varying past 30-day tobacco use into seven categories: (1) non-current use; exclusive use of 2) cigarettes, 3) electronic nicotine delivery systems (ENDS), or 4) other combustible products (OC; pipes, hookah, and cigars); dual use of 5) ENDS + cigarettes or ENDS + OC 6) cigarettes + OC; or 7) polyuse of all three products...
January 22, 2024: Research Square
https://read.qxmd.com/read/38229741/positive-allosteric-modulators-of-alpha7-nicotinic-acetylcholine-receptor-for-the-treatment-of-several-central-nervous-system-diseases
#3
EDITORIAL
Ahmed F Abdel-Magid
The invention in this patent application relates to spirocyclopropane-2-carboxamide derivatives represented generally by formula 1. These compounds are positive allosteric modulators of α7 nAChR and may be useful in preventing, treating, or ameliorating central nervous system diseases and disorders such as cognitive impairments in Alzheimer's disease, Parkinson's disease, schizophrenia, and L-DOPA-induced dyskinesia as well as inflammation and cough.
January 11, 2024: ACS Medicinal Chemistry Letters
https://read.qxmd.com/read/38229538/safety-of-e-cigarettes-and-nicotine-patches-as-stop-smoking-aids-in-pregnancy-secondary-analysis-of-the-pregnancy-trial-of-e-cigarettes-and-patches-prep-randomized-controlled-trial
#4
JOURNAL ARTICLE
Francesca Pesola, Katie Myers Smith, Anna Phillips-Waller, Dunja Przulj, Christopher Griffiths, Robert Walton, Hayden McRobbie, Tim Coleman, Sarah Lewis, Rachel Whitemore, Miranda Clark, Michael Ussher, Lesley Sinclair, Emily Seager, Sue Cooper, Linda Bauld, Felix Naughton, Peter Sasieni, Isaac Manyonda, Peter Hajek
AIMS: The aim of this study was to examine the safety of e-cigarettes (EC) and nicotine patches (NRT) when used to help pregnant smokers quit. DESIGN: A recent trial of EC versus NRT reported safety outcomes in the randomized arms. We conducted a further analysis based on product use. SETTING: Twenty-three hospitals in England and a stop-smoking service in Scotland took part. PARTICIPANTS: The participants comprised 1140 pregnant smokers...
January 17, 2024: Addiction
https://read.qxmd.com/read/38189560/electronic-cigarettes-for-smoking-cessation
#5
JOURNAL ARTICLE
Nicola Lindson, Ailsa R Butler, Hayden McRobbie, Chris Bullen, Peter Hajek, Rachna Begh, Annika Theodoulou, Caitlin Notley, Nancy A Rigotti, Tari Turner, Jonathan Livingstone-Banks, Tom Morris, Jamie Hartmann-Boyce
BACKGROUND: Electronic cigarettes (ECs) are handheld electronic vaping devices which produce an aerosol by heating an e-liquid. People who smoke, healthcare providers and regulators want to know if ECs can help people quit smoking, and if they are safe to use for this purpose. This is a review update conducted as part of a living systematic review. OBJECTIVES: To examine the safety, tolerability and effectiveness of using electronic cigarettes (ECs) to help people who smoke tobacco achieve long-term smoking abstinence, in comparison to non-nicotine EC, other smoking cessation treatments and no treatment...
January 8, 2024: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/38157243/effectiveness-of-the-quitsure-smartphone-app-for-smoking-cessation-findings-of-a-prospective-single-arm-trial
#6
JOURNAL ARTICLE
Apurvakumar Pandya, Mythri K S, Shweta Mishra, Kriti Bajaj
BACKGROUND: Digital therapies, especially smartphone apps for active and continuous smoking cessation support, are strongly emerging as an alternative smoking cessation therapy. In the Indian context, there is a growing interest in the use of app-based smoking cessation programs; however, there is limited evidence regarding their effectiveness in achieving long-term continuous abstinence. OBJECTIVE: This study aimed to evaluate the long-term abstinence effect (up to 30-d abstinence postprogram completion) of a smartphone app, QuitSure, for smoking cessation in active smokers from India...
December 29, 2023: JMIR Formative Research
https://read.qxmd.com/read/38081374/ends-cigarettes-and-respiratory-illness-longitudinal-associations-among-us-youth
#7
JOURNAL ARTICLE
Richa Mukerjee, Jana L Hirschtick, Luis Zavala Arciniega, Yanmei Xie, Geoffrey Barnes, Douglas Arenberg, David T Levy, Rafael Meza, Nancy L Fleischer, Steven Cook
INTRODUCTION: Electronic nicotine delivery system (ENDS) use is highly prevalent among U.S. youth, and there is concern about its respiratory health effects. However, evidence from nationally representative longitudinal data is limited. METHODS: Using youth data (ages 12-17) from waves 1-5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study, multilevel Poisson regression models were estimated to examine the association between ENDS use, cigarettes, and diagnosed bronchitis, pneumonia, or chronic cough...
December 9, 2023: American Journal of Preventive Medicine
https://read.qxmd.com/read/38059181/characterization-of-e-cigarette-users-according-to-device-type-use-behaviors-and-self-reported-health-outcomes-findings-from-the-emit-study
#8
JOURNAL ARTICLE
Anna Tillery, Angela Aherrera, Rui Chen, Joyce J Y Lin, Mina Tehrani, Donia Moustafa, Jana Mihalic, Ana Navas-Acien, Ana M Rule
INTRODUCTION: Electronic cigarettes (e-cigarettes) rapidly evolved from large modifiable (MOD) devices, to small and affordable 'POD' devices. Detailed information on user demographics and preferences according to device type, which can inform potential chemical exposure and policy recommendations, is currently limited. The goal of this study is to describe user demographics, use behaviors and preferences, as well as self-reported health outcomes according to the e-cigarette device type used...
2023: Tobacco Induced Diseases
https://read.qxmd.com/read/37857323/e-cigarette-use-associated-lung-injury-evali
#9
JOURNAL ARTICLE
Nathaly Yessenia Tituana, Claudia Gabriela Clavijo, Evelyn Fernanda Espinoza, Viviana Alexandra Tituana
The prevalence of vaping has overtaken conventional cigarettes as the most frequent form of nicotine consumption among 15-24-year olds. There are currently a large number of both legitimate and illegitimate products and suppliers offering more than 8000 different flavors of vape on the market, whose additives are not tested, studied or regulated and whose safety and toxicity profile remains unknown. In vitro studies have demonstrated a dose-dependent decrease in the viability of normal human bronchial epithelial cells after exposure to vapor from electronic vape devices...
January 2024: Pneumologie
https://read.qxmd.com/read/37791243/inductive-characterization-of-ends-associated-adverse-events-among-california-young-adults
#10
JOURNAL ARTICLE
Joshua S Yang, Pauline Lim, Kristen Ojeda, Raphael E Cuomo, Vidya Purushothaman, Tim Mackey
INTRODUCTION: Previous studies have identified numerous adverse events experienced with the use of ENDS or E-cigarettes. However, much remains unknown about adverse event frequency, duration, and response experienced by users. The purpose of this study was to inductively characterize ENDS-attributed adverse events among young adults. METHODS: Sixteen focus groups were held with 114 young adults (aged 18-29 years) who have reported lifetime ENDS use in April 2021...
December 2022: AJPM Focus
https://read.qxmd.com/read/37738584/the-emerging-cloud-a-survey-of-vapers-their-health-and-utilisation-of-healthcare-within-the-united-kingdom
#11
JOURNAL ARTICLE
Lachlan J Sund, Paul I Dargan, John R H Archer, Matthew S Blundell, David M Wood
BACKGROUND: Recent work in the UK estimated the prevalence of current cannabinoid-based vaping to be higher than in the US, a factor previously associated with EVALI. Research in the US has demonstrated that attendances to emergency departments relating to e-cigarettes began to rise before the EVALI outbreak, suggesting that vapers also experience milder forms of vaping related illness. AIM: Quantify symptom prevalence and healthcare utilisation amongst current UK vapers...
September 21, 2023: QJM: Monthly Journal of the Association of Physicians
https://read.qxmd.com/read/37644524/nicotine-dependence-and-associated-factors-among-persons-who-use-electronic-e-cigarettes-in-malaysia-an-online-survey
#12
JOURNAL ARTICLE
Chandrashekhar T Sreeramareddy, Sameeha Misriya Shroff, Shilpa Gunjal
BACKGROUND: Nicotine dependence, factors associated with dependence, and self-reported side effects among people who use e-cigarettes are scarce in developing countries. METHODS: A sample of 302 persons who currently use e-cigarettes was recruited from discussion forums on Reddit, Facebook, and the forum 'lowyat'. The online Google form survey collected data on demographics, e-cigarette use, and the reasons, for cigarette smoking, Fagerstorm Test for Nicotine Dependence adapted for e-cigarettes (eFTND), and side effects experienced...
August 29, 2023: Substance Abuse Treatment, Prevention, and Policy
https://read.qxmd.com/read/37501282/from-bench-to-bedside-the-role-of-cough-hypersensitivity-in-chronic-cough
#13
REVIEW
Matthew G Drake, Lorcan P McGarvey, Alyn H Morice
BACKGROUND: Chronic cough is a burdensome condition characterized by persistent cough lasting longer than 8 weeks. Chronic cough can significantly affect quality of life, physical function and productivity, with many people troubled with a cough that lasts for months or even years. People with chronic cough commonly report a persistent urge to cough with frequent bouts of coughing triggered by innocuous stimuli, which has led to the concept of cough hypersensitivity. MAIN BODY: Both central and peripheral neural pathways regulate cough, and although mechanisms driving development of cough hypersensitivity are not fully known, sensitization of these neural pathways contributes to excessive cough triggering in cough hypersensitivity...
August 2023: Clinical and Translational Medicine
https://read.qxmd.com/read/37452334/the-efficacy-and-safety-of-varenicline-nasal-spray-for-the-management-of-dry-eye-signs-a-systematic-review-and-meta-analysis
#14
JOURNAL ARTICLE
Bader Bashrahil, Nada Taher, Ziyad Alzahrani, Ahmed Alnabihi, Abdulaziz Aldahlawi, Mohammed Alkhathlan, Saeed Alghamdi
BACKGROUND: Dry eye disease (DED) is caused by a persistently unstable tear film leading to ocular discomfort and is treated mainly with tear supplementation. There is emerging evidence that nicotinic acetylcholine receptor (nAChR) agonists (e.g., varenicline and simpinicline) nasal sprays are effective for DED. Our systematic review and meta-analysis assessed the efficacy and safety of varenicline nasal spray (VNS) for DED treatment. METHODS: The Medline, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) databases were searched...
July 14, 2023: BMC Ophthalmology
https://read.qxmd.com/read/37405948/reply-to-myslivecek
#15
JOURNAL ARTICLE
Elenia Cinelli, Ludovica Iovino, Fulvia Bongianni, Tito Pantaleo, Federico Lavorini, Claudia Mannini, Donatella Mutolo
No abstract text is available yet for this article.
July 1, 2023: American Journal of Physiology. Lung Cellular and Molecular Physiology
https://read.qxmd.com/read/37295884/a-40-year-old-man-with-multiple-pulmonary-nodules-and-mediastinal-lymphadenopathy-with-positive-anti-neutrophil-cytoplasmic-antibody-reveals-an-unexpected-diagnosis
#16
Brian Schroeder, Hussein Asad, Matthew C Aboudara
A 40-year-old man with no significant medical history presented to the ED with a 2-day history of right-sided chest pain accompanied by night sweats and chills. These symptoms were accompanied by a dry, nonproductive cough without hemoptysis. The patient worked as an air traffic controller, with a side business of buying, renovating, and selling houses. He takes part in the remodeling work himself but denies any exposure to animal droppings, bird droppings, or mold. He denied chronic sinus disease, rash, or arthralgias...
June 2023: Chest
https://read.qxmd.com/read/37132177/common-adverse-events-of-electronic-cigarettes-compared-with-traditional-nicotine-replacement-therapies-a-systematic-review-and-meta-analysis
#17
REVIEW
Aathavan Shanmuga Anandan, Janni Leung, Gary C K Chan, Tianze Sun, Jason P Connor, Wayne D Hall, Daniel Stjepanović
ISSUES: Established literature suggests that electronic cigarettes (EC) are more effective than traditional nicotine replacement therapies (NRT) as a smoking cessation aid, but the factors that mediate this difference remain poorly understood. We examine how adverse events (AE) associated with EC use relative to NRTs differ, with the view that differences in AEs experienced may drive differences in use and compliance. APPROACH: Papers for inclusion were identified via a three-tiered search strategy...
May 2, 2023: Drug and Alcohol Review
https://read.qxmd.com/read/37058347/a-new-questionnaire-to-assess-respiratory-symptoms-the-respiratory-symptom-experience-scale-quantitative-psychometric-assessment-and-validation-study
#18
JOURNAL ARTICLE
Saul Shiffman, Stacey A McCaffrey, Michael J Hannon, Nicholas I Goldenson, Ryan A Black
BACKGROUND: Smokers often experience respiratory symptoms (eg, morning cough), and those who stop smoking, including those who do so by switching completely to electronic nicotine delivery systems (ENDS), may experience reductions in symptoms. Existing respiratory symptom questionnaires may not be suitable for studying these changes, as they are intended for patient populations, such as those with chronic obstructive pulmonary disease (COPD). OBJECTIVE: This study aimed to develop a respiratory symptom questionnaire appropriate for current smokers and for assessing changes when smokers stop smoking...
April 14, 2023: JMIR Formative Research
https://read.qxmd.com/read/37014673/comparing-the-effectiveness-tolerability-and-acceptability-of-heated-tobacco-products-and-refillable-electronic-cigarettes-for-cigarette-substitution-ceasefire-randomized-controlled-trial
#19
JOURNAL ARTICLE
Pasquale Caponnetto, Davide Campagna, Marilena Maglia, Francesca Benfatto, Rosalia Emma, Massimo Caruso, Grazia Caci, Barbara Busà, Alfio Pennisi, Maurizio Ceracchi, Marcello Migliore, Maria Signorelli
BACKGROUND: People who smoke and who face challenges trying to quit or wish to continue to smoke may benefit by switching from traditional cigarettes to noncombustible nicotine delivery alternatives, such as heated tobacco products (HTPs) and electronic cigarettes (ECs). HTPs and ECs are being increasingly used to quit smoking, but there are limited data about their effectiveness. OBJECTIVE: We conducted the first randomized controlled trial comparing quit rates between HTPs and ECs among people who smoke and do not intend to quit...
April 4, 2023: JMIR Public Health and Surveillance
https://read.qxmd.com/read/37008740/associations-between-biomarkers-of-nicotine-tobacco-exposure-and-respiratory-symptoms-among-adults-who-exclusively-smoke-cigarettes-in-the-u-s-findings-from-the-path-study-waves-1-4-2013-2017
#20
JOURNAL ARTICLE
Kathryn C Edwards, Jenny E Ozga, Carolyn Reyes-Guzman, Danielle Smith, Dorothy Hatsukami, Joy L Hart, Asti Jackson, Maciej Goniewicz, Cassandra A Stanton
SIGNIFICANCE: Determining if tobacco-related biomarkers of exposure (BOE) are associated with respiratory symptoms is an important public health tool that can be used to evaluate the potential harm of different tobacco products. METHODS: Adult data from people who exclusively smoked cigarettes (N = 2,438) in Waves 1-4 (2013-2017) of the Population Assessment of Tobacco and Health Study were stacked to examine associations between baseline and follow-up within wave pairs (W1-W2, W2-W3, W3-W4)...
June 2023: Addictive Behaviors Reports
keyword
keyword
90345
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.